CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up

被引:35
作者
Berg, Inger Jorid [1 ]
Semb, Anne Grete [2 ]
van der Heijde, Desiree [1 ,3 ]
Kvien, Tore K. [1 ]
Olsen, Inge C. [1 ]
Dagfinrud, Hanne [1 ]
Provan, Sella A. [1 ]
机构
[1] Diakonhjemmet Hosp, Dept Rheumatol, N-0319 Oslo, Norway
[2] Diakonhjemmet Hosp, Dept Rheumatol, Prevent Cardiorheuma Clin, N-0319 Oslo, Norway
[3] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
关键词
SUBCLINICAL ATHEROSCLEROSIS; INFLAMMATION; MORTALITY;
D O I
10.1136/annrheumdis-2014-206773
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective To identify factors associated with elevated arterial stiffness in a 5-year follow-up of patients with ankylosing spondylitis (AS). Methods C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), Bath AS disease activity index (BASDAI) and AS disease activity score (ASDAS) were recorded in 2003, and arterial stiffness (Augmentation Index (AIx) and pulse wave velocity (PWV)) in 2008/2009. Patients were grouped into quartiles according to baseline CRP, ESR and BASDAI and four ASDAS groups. Trend analyses were performed using ANCOVA (AIx/PWV as dependent variable) with separate models for CRP, ESR, BASDAI and ASDAS (age and gender adjusted). Independent predictors of future AIx and PWV levels were identified in multivariate linear regression models. Results In total, 85 patients participated. Increasing baseline values of CRP, ESR and ASDAS were associated with elevated AIx on follow-up (p(trend) 0.01, 0.05 and 0.04, respectively). Similar non-significant patterns were seen for PWV. In the multivariate analyses, baseline CRP and ASDAS were independently associated with future elevated AIx (p=0.03 and 0.02, respectively). In the multivariate PWV model, results for CRP and ASDAS were non-significant. Conclusions Baseline CRP and ASDAS were associated with future elevated arterial stiffness measured as AIx, supporting that disease activity is related to future risk of cardiovascular disease in patients with AS.
引用
收藏
页码:1562 / 1566
页数:5
相关论文
共 21 条
[1]
Increased mortality in ankylosing spondylitis is related to disease activity [J].
Bakland, Gunnstein ;
Gran, Jan Tore ;
Nossent, Johannes C. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (11) :1921-1925
[2]
Assessment of Subclinical Vascular Disease Associated with Ankylosing Spondylitis [J].
Bodnar, Nora ;
Kerekes, Gyoergy ;
Seres, Ildiko ;
Paragh, Gyoergy ;
Kappelmayer, Janos ;
Nemethne, Zsuzsanna Gyurcsik ;
Szegedi, Gyula ;
Shoenfeld, Yehuda ;
Sipka, Sandor ;
Soltesz, Pal ;
Szekanecz, Zoltan ;
Szanto, Sandor .
JOURNAL OF RHEUMATOLOGY, 2011, 38 (04) :723-729
[3]
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis [J].
Braun, J. ;
van den Berg, R. ;
Baraliakos, X. ;
Boehm, H. ;
Burgos-Vargas, R. ;
Collantes-Estevez, E. ;
Dagfinrud, H. ;
Dijkmans, B. ;
Dougados, M. ;
Emery, P. ;
Geher, P. ;
Hammoudeh, M. ;
Inman, R. D. ;
Jongkees, M. ;
Khan, M. A. ;
Kiltz, U. ;
Kvien, T. K. ;
Leirisalo-Repo, M. ;
Maksymowych, W. P. ;
Olivieri, I. ;
Pavelka, K. ;
Sieper, J. ;
Stanislawska-Biernat, E. ;
Wendling, D. ;
Ozgocmen, S. ;
van Drogen, C. ;
van Royen, B. J. ;
van der Heijde, D. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) :896-904
[4]
Investigation of effects of different treatment modalities on structural and functional vessel wall properties in patients with ankylosing spondylitis [J].
Capkin, Erhan ;
Kiris, Abdulkadir ;
Karkucak, Murat ;
Durmus, Ismet ;
Gokmen, Ferhat ;
Cansu, Aysegul ;
Tosun, Mehmet ;
Ayar, Ahmet .
JOINT BONE SPINE, 2011, 78 (04) :378-382
[5]
Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study [J].
Erre, Gian Luca ;
Sanna, Pietro ;
Zinellu, Angelo ;
Ponchietti, Alessandra ;
Fenu, Patrizia ;
Sotgia, Salvatore ;
Carru, Ciriaco ;
Ganau, Antonello ;
Passiu, Giuseppe .
CLINICAL RHEUMATOLOGY, 2011, 30 (01) :21-27
[6]
GARRETT S, 1994, J RHEUMATOL, V21, P2286
[7]
Inflammation and atherosclerosis [J].
Hansson, Goran K. ;
Robertson, Anna-Karin L. ;
Soderberg-Naucler, Cecilia .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2006, 1 (01) :297-329
[8]
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials [J].
Kearney, Patricia M. ;
Baigent, Colin ;
Godwin, Jon ;
Halls, Heather ;
Emberson, Jonathan R. ;
Patrono, Carlo .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7553) :1302-1305
[9]
Validated methods for assessment of subclinical atherosclerosis in rheumatology [J].
Kerekes, Gyoergy ;
Soltesz, Pal ;
Nurmohamed, Michael T. ;
Gonzalez-Gay, Miguel A. ;
Turiel, Maurizio ;
Edit Vegh ;
Shoenfeld, Yehuda ;
McInnes, Iain ;
Szekanecz, Zoltan .
NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (04) :224-234
[10]
Expert consensus document on arterial stiffness: methodological issues and clinical applications [J].
Laurent, Stephane ;
Cockcroft, John ;
Van Bortel, Luc ;
Boutouyrie, Pierre ;
Giannattasio, Cristina ;
Hayoz, Daniel ;
Pannier, Bruno ;
Vlachopoulos, Charalambos ;
Wilkinson, Ian ;
Struijker-Boudier, Harry .
EUROPEAN HEART JOURNAL, 2006, 27 (21) :2588-2605